Lisa A. Marsch

NYU Grossman School of Medicine

NIH Rank #3019
  • Program Leader
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$2.8M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#3,019
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.8M across 3 grants · National rank #3019.

Top grants by award amount

Lisa A. Marsch's NIH grant portfolio, ranked by award amount.

  • 4U01DA047982-02U01
    Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults
    $2.5M
    award amount
  • 5P30DA029926-14P30
    Technology-based Treatments for Substance Use Disorders
    $144.8K
    award amount
  • 5UG1DA040309-10UG1
    Northeast Node of the National Drug Abuse Clinical Trials Network
    $136.6K
    award amount

Affiliations

Institutions that have administered grants for Lisa A. Marsch.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    NYU Grossman School of Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3019
  6. 2024
    Entered Top 25% Nationally
    Ranked #3019
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions